CN Stock MarketDetailed Quotes

Guangdong Lifestrong Pharmacy (301111)

Watchlist
  • 18.84
  • -0.06-0.32%
Market Closed Apr 24 15:00 CST
3.01BMarket Cap-166.73P/E (TTM)

Guangdong Lifestrong Pharmacy (301111) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Total operating revenue
-0.14%228.41M
1.58%154.78M
-0.54%70.81M
-4.71%278.64M
11.02%228.74M
3.77%152.37M
-10.22%71.2M
3.20%292.4M
0.04%206.04M
9.50%146.84M
Operating revenue
-0.14%228.41M
1.58%154.78M
-0.54%70.81M
-4.71%278.64M
11.02%228.74M
3.77%152.37M
-10.22%71.2M
3.20%292.4M
0.04%206.04M
9.50%146.84M
Other operating revenue
----
141.64%918.84K
----
1,701.95%4.45M
----
243.85%380.25K
----
428.47%246.79K
----
266.44%110.59K
Total operating cost
8.11%247.99M
14.67%169.02M
17.74%77.31M
7.23%285.96M
22.48%229.4M
15.68%147.39M
-0.79%65.67M
2.98%266.69M
-0.78%187.3M
8.93%127.41M
Operating cost
-5.20%87.35M
-7.58%56.94M
8.46%26.79M
-8.24%84.37M
37.96%92.14M
23.78%61.61M
-4.72%24.7M
-0.18%91.95M
1.37%66.79M
16.53%49.77M
Operating tax surcharges
5.93%3.39M
0.63%2.33M
-0.40%1.12M
2.14%4.38M
5.86%3.2M
7.62%2.32M
2.53%1.12M
4.09%4.29M
13.21%3.02M
27.91%2.15M
Operating expense
12.79%113.69M
23.31%80.47M
14.95%34.67M
-0.95%137.13M
5.52%100.8M
6.03%65.26M
-8.68%30.16M
0.45%138.45M
-5.90%95.52M
2.71%61.54M
Administration expense
26.33%35.9M
64.07%24.77M
61.07%12.67M
98.81%51.41M
61.52%28.42M
35.64%15.1M
67.95%7.86M
43.26%25.86M
35.28%17.59M
30.69%11.13M
Financial expense
162.77%987.92K
156.66%634K
154.43%244.25K
111.59%266.41K
15.06%-1.57M
16.58%-1.12M
36.88%-448.74K
-0.21%-2.3M
-21.58%-1.85M
-33.90%-1.34M
-Interest expense (Financial expense)
1,890.58%2.02M
5,694.75%1.35M
418.70%724.11K
568.23%2.46M
-50.51%101.52K
-64.68%23.38K
1,353.75%139.6K
1,226.14%368.7K
720.91%205.15K
241.14%66.17K
-Interest Income (Financial expense)
14.12%-1.47M
13.47%-1.01M
12.60%-524.1K
16.34%-2.26M
17.45%-1.72M
17.89%-1.17M
20.13%-599.67K
-14.73%-2.7M
-30.40%-2.08M
-33.96%-1.42M
Research and development
4.04%6.68M
-8.25%3.89M
-19.60%1.82M
-0.41%8.41M
3.15%6.42M
1.89%4.24M
4.44%2.26M
-7.84%8.44M
-13.77%6.22M
-19.00%4.16M
Credit Impairment Loss
-122.28%-291.89K
-470.09%-1.68M
-91.94%135.42K
88.90%-248.4K
36.92%1.31M
222.17%454.28K
1,211.93%1.68M
-364,329.67%-2.24M
-56.62%956.74K
945.39%141.01K
Asset Impairment Loss
-92.36%133.08K
-72.19%647.08K
6.13%1.48M
-112.79%-5.54M
479.35%1.74M
1,412.75%2.33M
592.26%1.39M
-313.42%-2.6M
18.90%-458.98K
151.12%153.82K
Other net revenue
-71.65%4.7M
-83.08%2.19M
-58.70%3.22M
-46.93%8.21M
1.26%16.57M
34.00%12.95M
80.06%7.79M
-17.47%15.47M
-11.98%16.36M
-16.80%9.66M
Fair value change income
-70.51%461.97K
-67.07%390.75K
-84.26%133.84K
-39.97%1.67M
-33.34%1.57M
-25.95%1.19M
11.86%850.05K
-5.12%2.78M
-13.85%2.35M
-11.80%1.6M
Invest income
-55.49%3.73M
-59.85%2.32M
-60.93%1.15M
-14.33%10.19M
-7.84%8.38M
-5.41%5.79M
-5.00%2.94M
-0.04%11.9M
-4.73%9.09M
1.76%6.12M
-Including: Investment income associates
-2,926.80%-1.52M
-31,342.76%-1.12M
----
---692.06K
---50.35K
---3.56K
----
----
----
----
Asset deal income
----
----
----
----
--1.79M
--1.79M
----
----
----
--0
Other revenue
-62.66%665.34K
-63.59%509.56K
-65.47%316.49K
-62.16%2.13M
-59.73%1.78M
-15.00%1.4M
2.00%916.57K
15.59%5.63M
-11.68%4.43M
-62.59%1.65M
Operating profit
-193.52%-14.88M
-167.22%-12.05M
-124.68%-3.29M
-97.85%884.1K
-54.67%15.91M
-38.36%17.93M
-23.65%13.32M
-4.46%41.18M
-1.86%35.11M
1.19%29.09M
Add:Non operating Income
-55.31%147.99K
-81.43%54.04K
-63.96%75.45K
104.13%399.06K
24.98%331.13K
38.11%291.01K
130.88%209.35K
-43.86%195.5K
-17.20%264.95K
22.70%210.71K
Less:Non operating expense
-90.89%142.57K
-92.46%106.53K
566.89%13.86K
-65.08%1.43M
295.03%1.56M
309.66%1.41M
-98.32%2.08K
-53.04%4.09M
-74.09%396.11K
112.45%344.67K
Total profit
-201.35%-14.88M
-172.01%-12.1M
-123.84%-3.22M
-100.38%-143.56K
-58.03%14.68M
-41.95%16.81M
-22.31%13.52M
7.31%37.29M
1.19%34.98M
0.69%28.95M
Less:Income tax cost
-606.92%-3.31M
-247.09%-1.94M
-57.20%878.82K
-129.03%-1.38M
-86.23%652.17K
-68.66%1.32M
-20.72%2.05M
257.23%4.76M
37.12%4.73M
27.64%4.21M
Net profit
-182.49%-11.57M
-165.62%-10.17M
-135.77%-4.1M
-96.20%1.24M
-53.62%14.03M
-37.41%15.49M
-22.59%11.47M
-2.65%32.53M
-2.80%30.24M
-2.80%24.75M
Net profit from continuing operation
-182.49%-11.57M
-165.62%-10.17M
-135.77%-4.1M
-96.20%1.24M
-53.62%14.03M
-37.41%15.49M
-22.59%11.47M
-2.65%32.53M
-2.80%30.24M
-2.80%24.75M
Net income from discontinuing operating
----
----
----
----
----
----
--0
----
----
----
Less:Minority Profit
-4,619.30%-3.44M
-859.85%-2.94M
-146.38%-661.47K
-201.75%-2.92M
70.71%-72.93K
795.32%386.96K
-540,323.51%-268.48K
-4,160,171.37%-969.34K
-1,285,554.26%-249.03K
---55.65K
Net profit of parent company owners
-157.65%-8.13M
-147.83%-7.22M
-129.32%-3.44M
-87.57%4.16M
-53.76%14.1M
-39.11%15.1M
-20.78%11.74M
0.25%33.5M
-2.00%30.49M
-2.58%24.81M
Earning per share
Basic earning per share
-157.66%-0.0508
-147.88%-0.0452
-128.57%-0.02
-85.71%0.03
-53.39%0.0881
-38.98%0.0944
-22.22%0.07
0.00%0.21
-2.83%0.189
-2.77%0.1547
Diluted earning per share
-157.66%-0.0508
-147.88%-0.0452
-128.57%-0.02
-85.71%0.03
-53.39%0.0881
-38.98%0.0944
-22.22%0.07
0.00%0.21
-2.83%0.189
-2.77%0.1547
Other composite income
Total composite income
-182.49%-11.57M
-165.62%-10.17M
-135.77%-4.1M
-96.20%1.24M
-53.62%14.03M
-37.41%15.49M
-22.59%11.47M
-2.65%32.53M
-2.80%30.24M
-2.80%24.75M
Total composite income of parent company owners
-157.65%-8.13M
-147.83%-7.22M
-129.32%-3.44M
-87.57%4.16M
-53.76%14.1M
-39.11%15.1M
-20.78%11.74M
0.25%33.5M
-2.00%30.49M
-2.58%24.81M
Total composite income of minority owners
-4,619.30%-3.44M
-859.85%-2.94M
-146.38%-661.47K
-201.75%-2.92M
70.71%-72.93K
795.32%386.96K
-540,323.51%-268.48K
-4,160,171.37%-969.34K
-1,285,554.26%-249.03K
---55.65K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Total operating revenue -0.14%228.41M1.58%154.78M-0.54%70.81M-4.71%278.64M11.02%228.74M3.77%152.37M-10.22%71.2M3.20%292.4M0.04%206.04M9.50%146.84M
Operating revenue -0.14%228.41M1.58%154.78M-0.54%70.81M-4.71%278.64M11.02%228.74M3.77%152.37M-10.22%71.2M3.20%292.4M0.04%206.04M9.50%146.84M
Other operating revenue ----141.64%918.84K----1,701.95%4.45M----243.85%380.25K----428.47%246.79K----266.44%110.59K
Total operating cost 8.11%247.99M14.67%169.02M17.74%77.31M7.23%285.96M22.48%229.4M15.68%147.39M-0.79%65.67M2.98%266.69M-0.78%187.3M8.93%127.41M
Operating cost -5.20%87.35M-7.58%56.94M8.46%26.79M-8.24%84.37M37.96%92.14M23.78%61.61M-4.72%24.7M-0.18%91.95M1.37%66.79M16.53%49.77M
Operating tax surcharges 5.93%3.39M0.63%2.33M-0.40%1.12M2.14%4.38M5.86%3.2M7.62%2.32M2.53%1.12M4.09%4.29M13.21%3.02M27.91%2.15M
Operating expense 12.79%113.69M23.31%80.47M14.95%34.67M-0.95%137.13M5.52%100.8M6.03%65.26M-8.68%30.16M0.45%138.45M-5.90%95.52M2.71%61.54M
Administration expense 26.33%35.9M64.07%24.77M61.07%12.67M98.81%51.41M61.52%28.42M35.64%15.1M67.95%7.86M43.26%25.86M35.28%17.59M30.69%11.13M
Financial expense 162.77%987.92K156.66%634K154.43%244.25K111.59%266.41K15.06%-1.57M16.58%-1.12M36.88%-448.74K-0.21%-2.3M-21.58%-1.85M-33.90%-1.34M
-Interest expense (Financial expense) 1,890.58%2.02M5,694.75%1.35M418.70%724.11K568.23%2.46M-50.51%101.52K-64.68%23.38K1,353.75%139.6K1,226.14%368.7K720.91%205.15K241.14%66.17K
-Interest Income (Financial expense) 14.12%-1.47M13.47%-1.01M12.60%-524.1K16.34%-2.26M17.45%-1.72M17.89%-1.17M20.13%-599.67K-14.73%-2.7M-30.40%-2.08M-33.96%-1.42M
Research and development 4.04%6.68M-8.25%3.89M-19.60%1.82M-0.41%8.41M3.15%6.42M1.89%4.24M4.44%2.26M-7.84%8.44M-13.77%6.22M-19.00%4.16M
Credit Impairment Loss -122.28%-291.89K-470.09%-1.68M-91.94%135.42K88.90%-248.4K36.92%1.31M222.17%454.28K1,211.93%1.68M-364,329.67%-2.24M-56.62%956.74K945.39%141.01K
Asset Impairment Loss -92.36%133.08K-72.19%647.08K6.13%1.48M-112.79%-5.54M479.35%1.74M1,412.75%2.33M592.26%1.39M-313.42%-2.6M18.90%-458.98K151.12%153.82K
Other net revenue -71.65%4.7M-83.08%2.19M-58.70%3.22M-46.93%8.21M1.26%16.57M34.00%12.95M80.06%7.79M-17.47%15.47M-11.98%16.36M-16.80%9.66M
Fair value change income -70.51%461.97K-67.07%390.75K-84.26%133.84K-39.97%1.67M-33.34%1.57M-25.95%1.19M11.86%850.05K-5.12%2.78M-13.85%2.35M-11.80%1.6M
Invest income -55.49%3.73M-59.85%2.32M-60.93%1.15M-14.33%10.19M-7.84%8.38M-5.41%5.79M-5.00%2.94M-0.04%11.9M-4.73%9.09M1.76%6.12M
-Including: Investment income associates -2,926.80%-1.52M-31,342.76%-1.12M-------692.06K---50.35K---3.56K----------------
Asset deal income ------------------1.79M--1.79M--------------0
Other revenue -62.66%665.34K-63.59%509.56K-65.47%316.49K-62.16%2.13M-59.73%1.78M-15.00%1.4M2.00%916.57K15.59%5.63M-11.68%4.43M-62.59%1.65M
Operating profit -193.52%-14.88M-167.22%-12.05M-124.68%-3.29M-97.85%884.1K-54.67%15.91M-38.36%17.93M-23.65%13.32M-4.46%41.18M-1.86%35.11M1.19%29.09M
Add:Non operating Income -55.31%147.99K-81.43%54.04K-63.96%75.45K104.13%399.06K24.98%331.13K38.11%291.01K130.88%209.35K-43.86%195.5K-17.20%264.95K22.70%210.71K
Less:Non operating expense -90.89%142.57K-92.46%106.53K566.89%13.86K-65.08%1.43M295.03%1.56M309.66%1.41M-98.32%2.08K-53.04%4.09M-74.09%396.11K112.45%344.67K
Total profit -201.35%-14.88M-172.01%-12.1M-123.84%-3.22M-100.38%-143.56K-58.03%14.68M-41.95%16.81M-22.31%13.52M7.31%37.29M1.19%34.98M0.69%28.95M
Less:Income tax cost -606.92%-3.31M-247.09%-1.94M-57.20%878.82K-129.03%-1.38M-86.23%652.17K-68.66%1.32M-20.72%2.05M257.23%4.76M37.12%4.73M27.64%4.21M
Net profit -182.49%-11.57M-165.62%-10.17M-135.77%-4.1M-96.20%1.24M-53.62%14.03M-37.41%15.49M-22.59%11.47M-2.65%32.53M-2.80%30.24M-2.80%24.75M
Net profit from continuing operation -182.49%-11.57M-165.62%-10.17M-135.77%-4.1M-96.20%1.24M-53.62%14.03M-37.41%15.49M-22.59%11.47M-2.65%32.53M-2.80%30.24M-2.80%24.75M
Net income from discontinuing operating --------------------------0------------
Less:Minority Profit -4,619.30%-3.44M-859.85%-2.94M-146.38%-661.47K-201.75%-2.92M70.71%-72.93K795.32%386.96K-540,323.51%-268.48K-4,160,171.37%-969.34K-1,285,554.26%-249.03K---55.65K
Net profit of parent company owners -157.65%-8.13M-147.83%-7.22M-129.32%-3.44M-87.57%4.16M-53.76%14.1M-39.11%15.1M-20.78%11.74M0.25%33.5M-2.00%30.49M-2.58%24.81M
Earning per share
Basic earning per share -157.66%-0.0508-147.88%-0.0452-128.57%-0.02-85.71%0.03-53.39%0.0881-38.98%0.0944-22.22%0.070.00%0.21-2.83%0.189-2.77%0.1547
Diluted earning per share -157.66%-0.0508-147.88%-0.0452-128.57%-0.02-85.71%0.03-53.39%0.0881-38.98%0.0944-22.22%0.070.00%0.21-2.83%0.189-2.77%0.1547
Other composite income
Total composite income -182.49%-11.57M-165.62%-10.17M-135.77%-4.1M-96.20%1.24M-53.62%14.03M-37.41%15.49M-22.59%11.47M-2.65%32.53M-2.80%30.24M-2.80%24.75M
Total composite income of parent company owners -157.65%-8.13M-147.83%-7.22M-129.32%-3.44M-87.57%4.16M-53.76%14.1M-39.11%15.1M-20.78%11.74M0.25%33.5M-2.00%30.49M-2.58%24.81M
Total composite income of minority owners -4,619.30%-3.44M-859.85%-2.94M-146.38%-661.47K-201.75%-2.92M70.71%-72.93K795.32%386.96K-540,323.51%-268.48K-4,160,171.37%-969.34K-1,285,554.26%-249.03K---55.65K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Huaxing Certified Public Accountants (Special General Partnership)------Huaxing Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More